Skip to main content
Home
  • Home
  • About Reactiv8
  • For Clinicians
  • About Mainstay
  • News & Events
  • Investors
  • Careers
  • Contact Us
  • EN
  • FR
  • DE
  • NL
  • US
  • AU
Sub menu▸
  • Press Releases
  • News
  • Events
  • Contact Us

News

Date
Title
  • 15 Feb 2018
    Mainstay Releases 2017 Annual Report 
  • 24 Jun 2014
    Mainstay Medical featured as Showcase Technology Company at the Tech Tour and International Venture Club’s HEALTHTECH Summit 2014.
  • 14 Oct 2012
    Mainstay Medical Limited Awarded Neurotech’s Golden Electrode Award for Most Promising Startup

© Copyright 2017 Mainstay Medical Limited. All rights reserved.

Footer menu

  • Site Map
  • Contact Us
  • Impressum
  • Privacy Policy
  • Terms & Conditions
  • Commercial Terms & Conditions

ReActiv8 is CE marked for the treatment of chronic low back pain and available for sale in Europe.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show